Inhibitory effects of sertraline in rat isolated perfused kidneys and in isolated ring preparations of rat arteries

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 9, 2011, Pages 1186-1194

  Fonseca Magalhães, Patrícia A ^a   Sousa, Daniel F ^a   De Siqueira, Rodrigo J B ^a   Jorge, Roberta J B ^a   Meneses, Gdayllon C ^a   Alves, Renata S ^a   Monteiro, Helena S A ^a   Magalhães, Pedro J C ^a   Martins, Alice M C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

antidepressant; mesenteric artery; renal function; segmental renal artery; selective serotonin reuptake inhibitors

Indexed keywords

CAFFEINE; CALCIUM ION; PHENYLEPHRINE; SERTRALINE; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GLOMERULUS FILTRATION RATE; ISOLATED ARTERY; ISOLATED KIDNEY; KIDNEY VASCULAR RESISTANCE; MALE; MESENTERIC ARTERY; NONHUMAN; PERFUSION PRESSURE; RAT; RENAL ARTERY; SARCOLEMMA; SMOOTH MUSCLE RELAXATION; URINE FLOW RATE;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKERS; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; MESENTERY; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PARASYMPATHOLYTICS; PHENYLEPHRINE; PRESSURE; RATS; RATS, WISTAR; RENAL ARTERY; SARCOLEMMA; SERTRALINE; THAPSIGARGIN; URINATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATOR AGENTS; VERAPAMIL;

EID: 80051675145     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01317.x     Document Type: Article

References (33)

1. Muijsers RB, et al,. Sertraline: a review of its use in the management of major depressive disorder in elderly patients. Drugs Aging 2002; 19: 377-392. (Pubitemid 34804185)
2. Preskorn SH,. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 1997; 32 (Suppl. 1): 1-21. (Pubitemid 27107715)
3. Finkel SI, et al,. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004; 19: 9-18. (Pubitemid 38180687)
4. Löwe B, et al,. Efficacy, predictors of therapy response, and safety of sertraline in routine clinical practice: prospective, open-label, non-interventional postmarketing surveillance study in 1878 patients. J Affect Disord 2005; 87: 271-279. (Pubitemid 41039949)
5. Torta R, et al,. Sertraline effectiveness and safety in depressed oncological patients. Support Care Cancer 2008; 16: 83-91. (Pubitemid 350243754)
6. Dheenan S, et al,. Effect of sertraline hydrochloride on dialysis hypotension. Am J Kidney Dis 1998; 31: 624-630. (Pubitemid 28158002)
7. Perazella MA,. Pharmacologic options available to treat symptomatic intradialytic hypotension. Am J Kidney Dis 2001; 38: (4 Suppl. 4): S26-S36. (Pubitemid 32976706)
8. Yalcin AU, et al,. Effect of sertraline hydrochloride on cardiac autonomic dysfunction in patients with hemodialysis-induced hypotension. Nephron Physiol 2003; 93: P21-P28. (Pubitemid 37499912)
9. Wuerth D, et al,. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 2001; 37: 1011-1017. (Pubitemid 32436574)
10. Gruetter CA, et al,. Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine. Eur J Pharmacol 1992; 217: 109-118.
11. Vila JM, et al,. Relaxant effects of antidepressants on human isolated mesenteric arteries. Br J Clin Pharmacol 1999; 48: 223-229. (Pubitemid 29349459)
12. Becker B, et al,. Blockade of calcium entry in smooth muscle cells by the antidepressant imipramine. Biochem Pharmacol 2004; 68: 833-842. (Pubitemid 39044512)
13. van Melle JP, et al,. Sertraline causes strong coronary vasodilation: possible relevance for cardioprotection by selective serotonin reuptake inhibitors. Cardiovasc Drugs Ther 2004; 18: 441-447. (Pubitemid 40487022)
14. Fonteles MC, et al,. Support of kidney function by long-chain fatty acids derived from renal tissue. Am J Physiol 1983; 244: F235-F246. (Pubitemid 13115136)
15. Bowman RH,. Gluconeogenesis in the isolated perfused rat kidney. J Biol Chem 1970; 245: 1604-1612.
16. Martines-Maldonado M, et al,. Renal effects of lithium administration in rats: alterations in water and electrolyte metabolism and the response to vasopressin and cyclic-adenosine monophosphate during prolonged administration. J Lab Clin Med 1975; 86: 445-461.
17. Drew GM, Whiting SB,. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol 1979; 67: 207-215. (Pubitemid 10190239)
18. Nielsen H, et al,. Age-dependent changes in alpha-adrenoceptor-mediated contractility of isolated human resistance arteries. Am J Physiol 1992; 263 (4 Pt 2): H1190-H1196.
19. Awe SO, Adeagbo AS,. Vascular alpha1-adrenoceptors in isolated perfused rat kidney: influence of ageing. Auton Autacoid Pharmacol 2007; 27: 19-26. (Pubitemid 44952841)
20. Yaris E, et al,. The effects of paroxetine on rat isolated vas deferens. Pharmacol Res 2003; 48: 335-345. (Pubitemid 36945332)
21. Medina P, et al,. Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology 2000; 55: 592-597. (Pubitemid 30157977)
22. Baldessarini RJ,. Drug therapy of depression and anxiety disorders. In:, Brunton LL, et al., ed. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 11th edn. New York: Mc-Graw Hill, 2006: 429-459.
23. Tremaine LM, et al,. Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab Dispos 1989; 17: 542-550. (Pubitemid 19244919)
24. Kadioglu M, et al,. Paroxetine inhibited the relaxations induced by EFS in mice corpus cavernosum: is it a NOS inhibition? Fundam Clin Pharmacol 2010; 24: 55-61.
25. Seo KK, et al,. Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies. J Urol 2001; 165 (6 Pt 1): 2110-2114.
26. Minneman KP, Esbenshade TA,. Alpha 1-adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol 1994; 34: 117-133.
27. Berridge MJ,. Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 2009; 1793: 933-940.
28. Hume JR, et al,. Caffeine inhibits InsP3 responses and capacitative calcium entry in canine pulmonary arterial smooth muscle cells. Vascul Pharmacol 2009; 50: 89-97.
29. 2+ entry pathway by PKC-epsilon in vascular SMCs. Am J Physiol Cell Physiol 2008; 294: C1499-C1508.
30. Somlyo AP, Somlyo AV,. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236. (Pubitemid 24352442)
31. Kalyoncu NI, et al,. Sertraline inhibits the contractile responses to noradrenaline, KCl and electrical field stimulation of rat isolated vas deferens. J Auton Pharmacol 1999; 19: 365-369. (Pubitemid 30616159)
32. Molin JC, Bendhack LM,. Clonidine induces rat aorta relaxation by nitric oxide-dependent and -independent mechanisms. Vascul Pharmacol 2004; 42: 1-6. (Pubitemid 40128136)
33. Somlyo AP, et al,. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 1999; 134: 201-234.